The short version
9 companies supply this market — a reasonable cushion if one runs into trouble.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Fenofibric acid
Fenofibric acid · CHOLINE FENOFIBRATE 135 mg/1 · Capsule, Delayed Release · Oral · Macleods Pharmaceuticals Limited
NDC 33342-0295-10 · 90 CAPSULE, DELAYED RELEASE in 1 BOTTLE · ANDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
90-day shortage risk (model v2)
0.1%chance of a new FDA shortage posting for fenofibric acid (oral solid) in the next 90 days
sole-source market · price up 7% YoY
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Where it's made
- analysis · label · manufacture · pack
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Regulatory
- Application
- ANDA207796
- TE code
- —
- Approval date
- Feb 8, 2024
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Fenofibric acid (Capsule, Delayed Release)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Amneal Pharmaceuticals of New York LLC | FENOFIBRIC ACID 135 mg/1 | Jul 15, 2026 | Sep 3, 2026 |
| Alembic Pharmaceuticals Inc. | FENOFIBRIC ACID 135 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Alembic Pharmaceuticals Inc. | FENOFIBRIC ACID 45 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Alembic Pharmaceuticals Limited | FENOFIBRIC ACID 45 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Alembic Pharmaceuticals Limited | FENOFIBRIC ACID 135 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Aurobindo Pharma Limited | FENOFIBRIC ACID 45 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Aurobindo Pharma Limited | FENOFIBRIC ACID 135 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Fournier Laboratories Ireland LTD | FENOFIBRIC ACID 135 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Fournier Laboratories Ireland LTD | FENOFIBRIC ACID 45 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Laurus Labs Limited | FENOFIBRIC ACID 135 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Laurus Labs Limited | FENOFIBRIC ACID 45 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Leading Pharma, LLC | FENOFIBRIC ACID 45 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Leading Pharma, LLC | FENOFIBRIC ACID 135 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Macleods Pharmaceuticals Limited | CHOLINE FENOFIBRATE 45 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Macleods Pharmaceuticals Limited | CHOLINE FENOFIBRATE 135 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Amneal Pharmaceuticals of New York LLC | FENOFIBRIC ACID 45 mg/1 | Jul 15, 2026 | Aug 29, 2026 |
| Micro Labs Limited | FENOFIBRIC ACID 45 mg/1 | Jul 15, 2026 | Aug 5, 2026 |
| Micro Labs Limited | FENOFIBRIC ACID 135 mg/1 | Jul 15, 2026 | Aug 5, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Fenofibric acid — NDC 33342-0295-10," retrieved September 3, 2026, https://drugdashboards.com/drug/33342029510.
Free to cite with attribution — see how the data is put together.